A Comparative Study of Two Different Techniques of Laparoscopic Herniotomy in Pediatric Population

Aim: This study evaluates the operative outcomes of two laparoscopic techniques for congenital inguinal hernia repair-Laparoscopic Intracorporeal Purse-String (LIPS) and Laparoscopic Sac Resection with Peritoneal Closure (LSRPC)-in terms of recurrence and testicular atrophy at 3 and 6 months. Settings and Design: A prospective observational study approved by the Institutional Ethics Committee. Participants, aged 6 months to 14 years, were randomized into two groups: Group I (LIPS) and Group II (LSRPC). For bilateral hernias, each side was repaired using different techniques through the same ports. Randomization was done using computer-based algorithms, ensuring no significant differences in anthropometric measurements. Methods and Material: Study Duration: February 2023 – October 2024 Inclusion Criteria: Children aged 6 months to 14 years with inguinal hernias Exclusion Criteria: Infants under 6 months, obstructed hernia, previous laparotomy, connective tissue disorders, ascites, ventriculo-peritoneal shunts, failure to obtain consent and recurrent hernias Statistical Analysis: Descriptive analysis was conducted using means, standard deviations, percentages and t-tests with SPSS software version 24.0; p<0.05 considered significant Results: Most surgeries were in children aged 5-10 years, with 64% undergoing LIPS and 52% undergoing LSRPC. At 3 months, recurrence occurred in 4% of the LIPS group and none in the LSRPC group. At 6 months, recurrence rates were 8% for LIPS and none for LSRPC. No cases of testicular atrophy were observed. Mean operative time was shorter for LIPS (20.2 minutes) than LSRPC (25.5 minutes), though this difference was not statistically significant. Conclusion: Both LIPS and LSRPC are safe, effective techniques with minimal recurrence and no testicular atrophy. Future studies should focus on longer follow-ups, larger sample sizes and cost-effectiveness. Key Messages: Both techniques were equally effective and safe, with minimal recurrence and no testicular atrophy for 6 months.